Asthma-treatment developer Vectura narrowed its first-half losses on the back of higher sales, while revealing plans for a special dividend and share buyback.
Stephen Fenby, Managing Director, bought 30,000 shares in the company on the 10th September 2019 at a price of 510.00p. The Director now holds 19,100,000...
Stuart Simpson, Executive Director, has re-invested 3,074 shares in the company on the 6th September 2019 at a price of 220.11p. The Director now holds...
Mark Williamson, Chairman, bought 1,489 shares in the company on the 6th September 2019 at a price of 2121.00p. The Director now holds 215,198 shares....